Skip to main content

Advertisement

Figure 4 | Stem Cell Research & Therapy

Figure 4

From: Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system

Figure 4

Effect of bone marrow mesenchymal stem cells on IFNγ + T cells in tumor-bearing mice ( n= 5). After bone marrow mesenchymal stem cell (BMSC) treatment in the pulmonary metastatic or H22 intraperitoneal hepatoma model, IFNγ+ T cells in peripheral blood white cells were detected during and after BMSC treatment. (A) IFNγ+ T-cell percentage in peripheral blood white cells of C57 mice. (B) IFNγ+ T-cell percentage in peripheral blood white cells of BALb/c mice. # P <0.05; § P <0.01 compared with the control group. IFNγ, interferon gamma.

Back to article page